MDM4 and neoplasm: To explore the role of MDM4 in tumorigenesis, malignant progression and tumor lethality, we evaluated the genomic heterogeneity index, which is known to affect clinical outcomes such as TMB, HRD, LOH, MATH, MSI, and Neoantigens.